A Design Team’s Views on Optimizing your Viral Vector for Clinical Success, ViroCell's workshop, Phacilitate, August 24, 2023, virtual

Vector design and optimization are critical to ensuring your candidate is stable, manufacturable, and ready to progress to clinical studies.

Delays often occur when a vector product has to be remade and it lands at the back of the manufacturing queue.  

Do you want to de-risk your critical vector and accelerate your pathway to the clinic?

Phacilitate & Team ViroCell are hosting ‘A Design Team’s Views on Optimizing your Viral Vector for Clinical Success’, a virtual interactive workshop to discuss strategies and learnings from their experience of manufacturing ~200 viral vectors for clinical trials.

On August 24th, Join CEO John W. Hadden II; Chief Scientific Officer Farzin Farzaneh, PhD; Director, Process Development & Innovation Carlo Scala, and Principal Scientist, Innovation Glenda J Dickson PhD.

For information on how to watch the video of the workshop, please email info@virocell.com